Evidence map›Paper›PMID 30947729›Full record

ArticleJournal of neuroinflammation2019

HIV-1 Tat enhances purinergic P2Y4 receptor signaling to mediate inflammatory cytokine production and neuronal damage via PI3K/Akt and ERK MAPK pathways.

Feng Zhou, Xiaomei Liu, Lin Gao, Xinxin Zhou, Qianwen Cao, Liping Niu, Jing Wang, Dongjiao Zuo, Xiangyang Li, Ying Yang and 10 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Occludin: a gatekeeper of brain Infection by HIV-1.Fluids and barriers of the CNS · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. CounterAKTing HIV: Toward a "Block and Clear" Strategy?Frontiers in cellular and infection microbiology · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 3 countries.

Feng ZhouJiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, People's Republic of China. zhoufeng-xzmc@163.com.ORCID http://orcid.org/0000-0001-8469-5548
Xiaomei LiuJiangsu Key Laboratory of Immunity and Metabolism and Department of Pathogen Biology and Immunology, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.
Lin GaoJiangsu Key Laboratory of Immunity and Metabolism and Department of Pathogen Biology and Immunology, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.
Xinxin ZhouDepartment of Chemical and Biological Engineering, Hanbat National University, Dongseodaero 125, Yuseong-gu, Daejeon, 305-719, South Korea.
Qianwen CaoJiangsu Key Laboratory of Immunity and Metabolism and Department of Pathogen Biology and Immunology, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.
Liping NiuJiangsu Key Laboratory of Immunity and Metabolism and Department of Pathogen Biology and Immunology, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.
Jing WangJiangsu Key Laboratory of Immunity and Metabolism and Department of Pathogen Biology and Immunology, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.
Dongjiao ZuoJiangsu Key Laboratory of Immunity and Metabolism and Department of Pathogen Biology and Immunology, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.
Xiangyang LiJiangsu Key Laboratory of Immunity and Metabolism and Department of Pathogen Biology and Immunology, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.
Ying YangJiangsu Key Laboratory of Immunity and Metabolism and Department of Pathogen Biology and Immunology, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.
Minmin HuJiangsu Key Laboratory of Immunity and Metabolism and Department of Pathogen Biology and Immunology, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.
Yinghua YuJiangsu Key Laboratory of Immunity and Metabolism and Department of Pathogen Biology and Immunology, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.
Renxian TangJiangsu Key Laboratory of Immunity and Metabolism and Department of Pathogen Biology and Immunology, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.
Bong Ho LeeDepartment of Chemical and Biological Engineering, Hanbat National University, Dongseodaero 125, Yuseong-gu, Daejeon, 305-719, South Korea.
Byoung Wook ChoiDepartment of Chemical and Biological Engineering, Hanbat National University, Dongseodaero 125, Yuseong-gu, Daejeon, 305-719, South Korea.
Yugang WangJiangsu Key Laboratory of Immunity and Metabolism and Department of Pathogen Biology and Immunology, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.
Yoshihiro IzumiyaDepartment of Dermatology, University of California Davis (UC Davis) School of Medicine, Sacramento, CA, USA.
Min XueDepartment of Physiology, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
Kuiyang ZhengJiangsu Key Laboratory of Immunity and Metabolism and Department of Pathogen Biology and Immunology, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.
Dianshuai GaoXuzhou Key Laboratory of Neurobiology, Department of Neurobiology and Anatomy, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China. gds@xzhmu.edu.cn.
Xuzhou Medical College · CNHanbat National University · KRUniversity of California, Davis · US

Funding

National Natural Science Foundation of China 81372598National Natural Science Foundation of China 81500914National Natural Science Foundation of China 81700794National Natural Science Foundation of China 81772688Natural Science Foundation of Jiangsu Province BK20141136Natural Science Foundation of Jiangsu Province BK20151168Priority Academic Program Development of Jiangsu Higher Education Institutions 2018 PAPDScience and Technology Support Program of Jiangsu Province (CN) KYLX18_2169
6 · The paper itself

Abstract

backgroundHIV-associated neurocognitive disorders (HANDs) afflict more than half of HIV-1-positive individuals. The transactivator of transcription (Tat) produced by HIV virus elicits inflammatory process and is a major neurotoxic mediator that induce neuron damage during HAND pathogenesis. Activated astrocytes are important cells involved in neuroinflammation and neuronal damage. Purinergic receptors expressed in astrocytes participate in a positive feedback loop in virus-induced neurotoxicity. Here, we investigated that whether P2Y4R, a P2Y receptor subtype, that expressed in astrocyte participates in Tat-induced neuronal death in vitro and in vivo.

methodsSoluble Tat protein was performed to determine the expression of P2Y4R and proinflammatory cytokines in astrocytes using siRNA technique via real-time PCR, Western blot, and immunofluorescence assays. Cytometric bead array was used to measure proinflammatory cytokine release. The TUNEL staining and MTT cell viability assay were analyzed for HT22 cell apoptosis and viability, and the ApopTag® peroxidase in situ apoptosis detection kit and cresyl violet staining for apoptosis and death of hippocampal neuron in vivo.

resultsWe found that Tat challenge increased the expression of P2Y4R in astrocytes. P2Y4R signaling in astrocytes was involved in Tat-induced inflammatory cytokine production via PI3K/Akt- and ERK1/2-dependent pathways. Knockdown of P2Y4R expression significantly reduced inflammatory cytokine production and relieved Tat-mediated neuronal apoptosis in vitro. Furthermore, in vivo challenged with Tat, P2Y4R knockdown mice showed decreased inflammation and neuronal damage, especially in hippocampal CA1 region.

conclusionsOur data provide novel insights into astrocyte-mediated neuron damage during HIV-1 infection and suggest a potential therapeutic target for HANDs.

Indexed as

Adenosine TriphosphateAnimalsAnimals, NewbornAstrocytesCells, CulturedCerebral CortexCytokinesEnzyme InhibitorsGene Expression RegulationGlial Fibrillary Acidic ProteinGliomaHumansMAP Kinase Signaling SystemMiceMice, Inbred C57BLNeuronsAdenosine TriphosphateCytokinesEnzyme InhibitorsGlial Fibrillary Acidic ProteinOncogene Protein v-aktPhosphatidylinositol 3-Kinasespurinoceptor P2Y4Receptors, Purinergic P2RNA, Messengertat Gene Products, Human Immunodeficiency VirusAstrocytesHIV-associated neurocognitive disordersInflammatory cytokinesPurinergic P2Y4 receptorTat

Identifiers

PMID30947729
PMCPMC6449963
OpenAlexW2944430654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.